PHARMACY WORLD & SCIENCE, cilt.27, sa.3, ss.243-248, 2005 (SCI-Expanded)
Objective of the study: To construct a simple model for an internal, retrospective cost-effectiveness analysis and to calculate the incremental cost-effectiveness of tissue plasminogen activator (TPA) over streptokinase (SK) in Turkey.